Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sugarfit offers a commercial digital health program for type 2 diabetes and prediabetes management and reversal. The company leverages continuous glucose monitoring devices, data analytics, personalized nutrition/fitness plans, and human coaching to help users improve glycemic control. Over 30,000 users have participated in its programs as of early 2024. Clinical results are not published in peer-reviewed journals but the company claims significant user engagement and positive outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sugarfit.